Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, M.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine), SCE (Endocrinology & Diabetes), MRCP (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine), SCE (Endocrinology & Diabetes), MRCP (UK)
Diabetologist
MBBS, FRCP (Ed.), FRCP (Glasg.), MRCP (UK), FACP (USA), FACC (USA), FASIM (USA), M.D
Diabetologist
MBBS, FRCP (Ed.), FRCP (Glasg.), MRCP (UK), FACP (USA), FACC (USA), FASIM (USA), M.D
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
Internal Medicine Specialist
B.Sc, MBBS (KEMU), FCPS(MED), MRCP(GLASGOW), DIP DIABETES(UK, AFPSIM(PAK), CMT(KE)
General Physician
MBBS, MCPS (Family Medicine)
General Physician
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Gastroenterology)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures